Clinical trial
Vitamin D and Calcium Homeostasis for Prevention of Type 2 Diabetes
NCT00436475 · Tufts Medical Center, Other · Completed
Key facts
| NCT number | NCT00436475 |
|---|---|
| Title | Vitamin D and Calcium Homeostasis for Prevention of Type 2 Diabetes |
| Official title | Vitamin D and Calcium Homeostasis for Prevention of Type 2 Diabetes |
| Acronym | CaDDM |
| Lead sponsor | Tufts Medical Center, Other |
| Collaborators | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) NIH |
| Status | Completed |
| Phase | Phase 1/Phase 2 |
| Study type | Interventional |
| Conditions | Glucose Intolerance, Type 2 Diabetes Mellitus, Metabolic Syndrome |
| Intervention type | Drug |
| Interventions | Vitamin D3 2, 000 IU orally once daily, Calcium Carbonate 400 mg orally twice daily, Vitamin D3-Placebo, Calcium-Placebo |
| Enrollment | 92 |
| Start date | Sep 1, 2007 |
| Primary completion | Nov 1, 2009 |
| Completion | Nov 1, 2009 |
| First posted | Feb 19, 2007 |
| Last update posted | Jul 30, 2019 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: